Catalog No. |
TD-JN076016 |
Species reactivity |
P. aeruginosa |
Applications |
Research Grade Biosimilar |
Host species |
Humanized |
Isotype |
VH-CH1-VH-V-KAPPA-CH2-CH3 |
Expression system |
Mammalian Cells |
Clonality |
Monoclonal |
Target |
PcrV & Psl |
Endotoxin level |
Please contact the lab for this information. |
Purity |
>95% purity as determined by SDS-PAGE. |
Purification |
Protein A/G, purified from cell culture supernatant. |
Accession |
O30527 |
Form |
Liquid |
Storage buffer |
0.01M PBS,pH7.4. |
Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
Alternate Names |
Bispecific,MEDI3902,CAS:1800381-36-5 |
Background |
Gremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas aeruginosa infections. |
Note |
For research use only. Not for use in clinical or therapeutic applications. |